112 related articles for article (PubMed ID: 7911603)
21. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes.
Wilding J; Vousden KH; Soutter WP; McCrea PD; Del Buono R; Pignatelli M
Cancer Res; 1996 Nov; 56(22):5285-92. PubMed ID: 8912870
[TBL] [Abstract][Full Text] [Related]
22. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells.
Al Moustafa AE; Foulkes WD; Benlimame N; Wong A; Yen L; Bergeron J; Batist G; Alpert L; Alaoui-Jamali MA
Oncogene; 2004 Jan; 23(2):350-8. PubMed ID: 14724563
[TBL] [Abstract][Full Text] [Related]
23. [Genetic abnormalities in lung cancer and their prognostic implications].
Mitsudomi T; Takahashi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
[TBL] [Abstract][Full Text] [Related]
24. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
25. [Cellular and neoplastic otorhinolaryngologic changes, molecular markers and therapeutic potential].
Blons H; Laccourreye O; Laurent-Puig P
Ann Otolaryngol Chir Cervicofac; 2003 Jun; 120(3):152-60. PubMed ID: 12843984
[TBL] [Abstract][Full Text] [Related]
26. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
27. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
[TBL] [Abstract][Full Text] [Related]
28. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy].
Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C
Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089
[TBL] [Abstract][Full Text] [Related]
29. [Molecular diagnosis of lung carcinoma].
Noguchi M
Rinsho Byori; 1994 Apr; 42(4):355-8. PubMed ID: 8176843
[TBL] [Abstract][Full Text] [Related]
30. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic considerations in the molecular epidemiology of head and neck cancer.
Brennan P; Boffetta P
IARC Sci Publ; 2004; (157):393-414. PubMed ID: 15055308
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
Giai M; Roagna R; Ponzone R; De Bortoli M; Dati C; Sismondi P
Anticancer Res; 1994; 14(3B):1441-50. PubMed ID: 7915096
[TBL] [Abstract][Full Text] [Related]
33. Molecular biology in the clinicopathologic assessment of endometrial carcinoma subtypes.
Boyd J
Gynecol Oncol; 1996 May; 61(2):163-5. PubMed ID: 8626127
[No Abstract] [Full Text] [Related]
34. Dominant oncogenes, tumor suppressors, and radiosensitivity.
Chiarugi V; Magnelli L; Cinelli M; Turchetti A; Ruggiero M
Cell Mol Biol Res; 1995; 41(3):161-6. PubMed ID: 8589756
[TBL] [Abstract][Full Text] [Related]
35. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
36. Oncogenes, molecular biology and the head and neck surgeon.
Irish JC
J Otolaryngol; 1992 Dec; 21 Suppl 3():1-20. PubMed ID: 1289578
[TBL] [Abstract][Full Text] [Related]
37. [Molecular biology in gastric cancer].
Kikuchi K; Ueda M; Kitajima M
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2139-46. PubMed ID: 10635296
[TBL] [Abstract][Full Text] [Related]
38. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
39. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
40. Molecular alterations in head and neck squamous cell carcinoma.
Bron L; Monnier P
Clin Otolaryngol Allied Sci; 1995 Aug; 20(4):291-8. PubMed ID: 8548956
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
